Autophagy is a catabolic process that has been implicated both as a tumor suppressor and in tumor progression. Here, we investigate this dichotomy in cancer biology by studying the influence of altered autophagy in Drosophila models of tissue overgrowth. We find that the impact of altered autophagy depends on both genotype and cell type. As previously observed in mammals, decreased autophagy suppresses Ras-induced eye epithelial overgrowth. In contrast, autophagy restricts epithelial overgrowth in a Notch-dependent eye model. Even though decreased autophagy did not influence Hippo pathway-triggered overgrowth, activation of autophagy strongly suppresses this eye epithelial overgrowth. Surprisingly, activation of autophagy enhanced Hippo pathway-driven overgrowth in glia cells. These results indicate that autophagy has different influences on tissue growth in distinct contexts, and highlight the importance of understanding the influence of autophagy on growth to augment a rationale therapeutic strategy.
INTRODUCTION
Autophagy is used to deliver cytoplasmic material to lysosomes for degradation. Autophagy is activated by multiple forms of stress, including reduced nutrient and oxygen levels, elevated levels of reactive oxygen species and organelle damage, many of which have been implicated in tumor formation and progression. 1 During autophagy, cargoes such as damaged organelles and protein aggregates are recruited into double-membrane autophagosome vesicles for clearance by fusion with lysosomes to form autolysosomes, where they are degraded by hydrolases. 2 Thus, autophagy serves to alleviate stress, and failure to do so could promote genetic alterations and tumor development. 3, 4 Although much is known about how autophagy (Atg) genes control this process based on studies in yeast, our understanding of the multiple potential roles of autophagy in animal cell, tissue and tumor biology remains rudimentary.
Autophagy has been implicated both as a tumor suppressor and in tumor progression. 5 This paradox may be explained by multiple possibilities, including inherent differences in the cells and tissues where tumors arise, the presence of secondary genetic alterations in tumor-promoting genes, and numerous others. For example, recent studies indicate that p53 status influences the impact of autophagy on K-Ras-triggered mouse models of pancreatic and lung cancers; loss of Atg gene function inhibits tumor progression in the presence of p53, but in the absence of p53 it accelerates tumor onset. 6, 7 In addition, much of what is known about the influence of autophagy on tumor biology is based on studies of the Beclin1/Atg6 gene, and it is now clear that this gene influences a wide variety of vesicle trafficking processes, including endocytosis, protein secretion and autophagy. 8, 9 Furthermore, whereas the role of autophagy in oncogenic Rasdriven tumor growth and the dependence on p53 status has been investigated, the influence of autophagy in different tumor contexts is largely unknown. Thus, studies on the role of autophagy in other tumor models are needed.
The fruit fly, Drosophila melanogaster, serves as a useful model to study epithelial growth, and the influence of oncogenes and tumor suppressors on epithelial overgrowth. Mammalian oncogenes and tumor suppressors are conserved in Drosophila and their deregulation can cause tissue overgrowth. 10, 11 For example, oncogenic Ras, which is associated with~30% of human tumors, 12 triggers epithelial overgrowth and also inhibits apoptosis in Drosophila. [13] [14] [15] Deregulation of Notch causes certain forms of cancer in humans, 16 and is also associated with severe overgrowth in Drosophila. One striking example of Notchinduced overgrowth is the eyeful phenotype, which is characterized by strong eye overgrowth and secondary metastasis-like growth. 17 Another growth-regulatory pathway that is deregulated in human cancer is the Hippo pathway, which was originally discovered in Drosophila. 18 Critical components in the Hippo pathway include the Hippo and Warts kinases, which prevent the transcriptional co-activator Yorkie (YAP in mammals) from translocating to the nucleus to induce cell proliferation. In addition, mutations in the tumor suppressor scribble (scrib) cause loss of apical-basal polarity, failure to differentiate and apoptosis that involves c-Jun N-terminal kinase (JNK)-induced signaling. 19 However, if scrib mutant cell clones are protected from apoptosis by expression of transgenes encoding dominant negative JNK (JNK DN ), the caspase inhibitor p35 or the oncogene Ras V12 (referred to as scrib+JNK DN , scrib+P35 or scrib+Ras V12 ), scrib mutant cells survive and unleash their full oncogenic activity, resulting in overproliferation and formation of neoplastic tissue masses. [20] [21] [22] The influence of autophagy on tissue overgrowth caused by most of these growth-regulatory factors is unknown. Here, we investigate the influence of altered autophagy on tissue overgrowth in Drosophila. We discover that the influence of loss and gain of autophagy differs depending on the growth-inducing stimulus and tissue. Like in mammals, autophagy is required for Ras-triggered epithelial overgrowth. In contrast, autophagy restricts increased epithelial growth in the Notch-dependent eyeful overgrowth model. Furthermore, increased growth driven by either loss of the growth regulator hippo or mis-expression of Yorkie is not influenced by decreased Atg gene function. Nevertheless, ectopic autophagy strongly suppresses epithelial overgrowth in these models. In contrast, activation of autophagy enhanced Yorkie-driven overgrowth in glia cells. These studies highlight the potential complexities of modulating autophagy in different in vivo models of cell and tissue overgrowth, and encourage a greater understanding of the influence of modulating autophagy for therapeutic purposes.
RESULTS
Autophagy can enhance or suppress tissue growth depending on genotype Studies in mammalian Ras-driven cancer models indicate that autophagy is required for tumor progression. 6, 7, 23 As previously described, expression of activated Ras V12 combined with loss of scrib in the Drosophila eye epithelium results in a strong tissue overgrowth phenotype (note the increase in GFP-expressing mutant tissue) compared with equivalent wild-type tissue (Figures 1a and aʹ). 20, 22 We analyzed the effect of reduced autophagy on scrib+Ras V12 -driven overgrowth by expression of RNAi against Atg1 (Atg1 IR ). Similar to mammalian K-Ras-driven models of cancer, Atg1 IR suppresses either scrib+Ras V12 -or Ras V12driven overgrowth (Figures 1c and cʹ and Supplementary Figures 1b and c; note the reduction in GFP-expressing mutant tissue), indicating that autophagy is required for tissue overgrowth.
Ras V12 not only protects cells from apoptosis, but also has other oncogenic effects that drive tumor growth. To uncouple these different effects of Ras V12 with respect to autophagy, we blocked apoptosis by the expression of either JNK DN or p35, but did not induce any other oncogenic activity. As reported previously, 20 inhibition of apoptosis is sufficient to trigger scrib-induced overgrowth in epithelial tissue (Figures 1d-g, note the increase in GFP-expressing mutant tissue compared with control). Surprisingly, in contrast to scrib+Ras V12 , in scrib mutants with impaired apoptosis by expression of either JNK DN or p35, reduction of autophagy using the same Atg1 RNAi transgene as in Figure 1c enhances scrib-induced overgrowth (Figures 1h and i; note the increase in GFP-expressing mutant tissue compared with tissue lacking GFP). Most strikingly, autophagy-deficient scrib+JNK DN cells make up almost the entire eye tissue (Figure 1h ), suggesting that autophagy restricts growth of apoptosis-inhibited scrib cell clones. Similarly, reduction of autophagy in apoptotic scrib mutant cells slightly increases clone size ( Supplementary Figures 1d and e ). These results indicate that oncogenic Ras V12 requires autophagy to drive strong tissue overgrowth; in the presence of Ras V12 autophagy promotes growth of scrib mutant tissue ( Figure 1c ), and in the absence of Ras V12 autophagy restricts tissue growth (Figures 1h and i) . These observations are consistent with data from mammalian tumor models and encourage further characterization of the role of autophagy in other oncogenic and cellular contexts in Drosophila.
Autophagy suppresses eyeful-induced tissue overgrowth
To examine the role of autophagy in a different oncogenic fly model, we used the established tissue overgrowth model called eyeful. eyeful is a Notch-dependent overgrowth model resulting from mis-expression of the Notch ligand Delta and of two chromatin modifiers, lola and pipsqueak, in the eye. 17 The eyeful phenotype consists of eye tissue overgrowth that ranges from mild overgrowth to overgrowth with tissue folds (Figures 2a, b , f and g), as well as less frequent secondary 'metastasis-like' eye growth in other parts of the body. 17 The eyeful-induced overgrowth is visible in developing larval antennal-eye precursor tissues, called imaginal discs (Figures 2l and m). To examine a potential contribution of autophagy to the eyeful phenotype, we decreased the function of 12 different Atg genes (Atg1, Atg6, Atg12, Atg5, Atg7, Atg4a, Atg4b, Atg8a, Atg8b, Atg3, Atg9 and Atg18) by RNAi. Strikingly, knockdown of any of these Atg genes strongly enhances eyeful-induced tissue overgrowth in both the adult eye (compare Figure 2) . Even more strikingly, these eyes do not only display enhanced overgrowth, but also often grow out from the eye in the form of projections (Figures 2h and i; arrows). Knockdown of the 12 Atg genes in the eyeful overgrowth model resulted in significant increases in the percentage of animals with eye projections (Figure 2k ). eyeful imaginal disc cells also possessed increased mCherry-Atg8 autophagy reporter puncta (compare Supplementary Figure 3dʹ Supplementary Figure 3d 00 with b 00 ). These data indicate that in the context of oncogenic Notch signaling autophagy restricts growth. This is in strong contrast to the influence of autophagy as an enhancer of Ras V12 -driven overgrowth ( Figure 1c ). These observations indicate that autophagy differentially influences tissue growth depending on the oncogenic activity in a given epithelium.
To further characterize the function of autophagy in tissue growth, we tested the effect of increased autophagy on the eyeful model. Expression of Atg1 is sufficient to induce autophagy in multiple Drosophila cell and tissue types. [24] [25] [26] Consistent with our loss-of-Atg gene function data, induction of autophagy by expression of Atg1 strongly suppresses eyeful-induced tissue overgrowth (Figures 3a and b ). We next addressed if suppression of eyeful tissue overgrowth by Atg1 expression depends on Atg gene function. To accomplish this task, we co-expressed Atg1 with RNAi transgenes targeting either Atg8 (Atg8 IR ) or Atg12 (Atg12 IR ) in eyeful animals and examined eye tissue overgrowth. Expression of either Atg8 IR or Atg12 IR reverts the Atg1-induced suppression of the eyeful overgrowth back to overgrown eye tissue (Figures 3c and d), indicating that suppression of eyeful overgrowth by Atg1 expression is dependent on the autophagy pathway. Taken together, these results indicate that ectopically induced autophagy functions as a suppressor of eyeful-induced tissue overgrowth.
Atg1-induced autophagy can induce either caspase-dependent or -independent cell death. 24, 25 Therefore, we assessed the role of caspases in the suppression of eyeful-induced overgrowth by Atg1 expression. To assay apoptotic cell death, we immuno-labeled larval antennal-eye disc tissues with antibodies to detect cleaved caspase-3. Interestingly, we observed cleaved caspases in eyeful larval eye discs alone (Figure 3e ), suggesting that eyeful induces apoptosis that is associated with overgrowth. Although Atg1 expression in eyeful tissue is also associated with elevated cleaved caspase-3 labeling (Figure 3f ), it is unclear if it is increased over eyeful alone (Figure 3e ). Importantly, cleaved caspase-3 labeling was observed when either Atg8 IR or Atg12 IR was co-expressed with Atg1 in eyeful tissue (Figures 3g and h) . Combined, these results suggest that cleaved caspase-3 labeling is associated with eyefulinduced tissue overgrowth, but does not appear to be associated with Atg1-triggered autophagy.
Our data suggest that apoptosis does not play a significant role in Atg1-dependent suppression of eyeful-induced tissue overgrowth. Nevertheless, because we observed cleaved caspase-3 in eyeful tissue (Figure 3e b, e and f). 18 We reduced autophagy by the expression of Atg8 IR in hippomutant cells. However, this treatment had little effect on either mutant cell clone or tissue size in imaginal discs and in adult heads (Figures 4c and g) . By contrast, induction of autophagy by mis-expression of Atg1 in hippomutant cell clones dramatically reduces mutant clone size in larval imaginal eye tissue and adult eyes (Figures 4d and h) . Thus, while endogenous autophagy does not restrict hippo --induced tissue overgrowth, the induction of autophagy strongly suppresses hippo --induced tissue overgrowth. Similarly, mis-expression of the Hippo pathway transcription factor Yorkie in the eye causes strong eye overgrowth, which is suppressed by simultaneous overexpression of Atg1 (Figures 4i and l). Analyses of imaginal discs showed that expression of Atg1 decreases Yorkie-induced cell proliferation based on the phospohistone H3 antibody staining ( Supplementary Figure 4) .
Our data indicate that modulation of autophagy has distinct impacts on eye epithelial growth depending on the genetic alteration that drives overgrowth. Since modulation of autophagy in hippo mutant cells had a modest influence on eye tissue growth, we tested if altered autophagy has an impact on growth of a different cell type, glia cells, undergoing Yorkie-induced overgrowth. 27 In addition, we examined the role of autophagy in Yorkie-induced glia overgrowth in a different tissue, the leg imaginal discs. Expression of Yorkie in glia cells of the leg imaginal discs strongly increases the number of glia cells using repo antibody as glia cell marker (Figures 5b and bʹ) . Ectopic induction of Atg1 slightly increases the number of repo-positive glia cells in leg discs (Figures 5c and cʹ) . Surprisingly, however, expression of Atg1 dramatically enhances Yorkie-induced glia overgrowth in larval leg discs (Figures 5d and dʹ) . A similar, although somewhat weaker, effect of Atg1-induced autophagy was observed in Yorkieinduced glia overgrowth in eye imaginal discs (Supplementary Figure 5 ). These observations are surprising as ectopic Atg1 expression acts as a strong suppressor of overgrowth in epithelial tissue (Figures 3b and 4d) , including hippo-induced overgrowth. Thus, while ectopic autophagy suppresses hippo-induced overgrowth in epithelial tissue, it enhances growth in the population of glia cells.
DISCUSSION
Substantial evidence indicates that autophagy can have distinct roles in different cellular contexts. In cancer, autophagy has been implicated in both tumor suppression and tumor progression. 5 Studies in mice indicate that autophagy restricts tumor initiation by restricting genome damage. 3, 4 By contrast, autophagy appears to promote tumor progression once tumors are established by enabling cancer cell survival. 23, 28 However, no previous study has systematically analyzed the influence of autophagy when either distinct oncogenic stimuli are activated within a single epithelial tissue, or if an identical oncogenic stimulus is activated in different cellular contexts.
Here we investigate the influence of autophagy in distinct epithelial cell contexts in Drosophila. We find that, like in mammals, autophagy promotes overgrowth in the context of a Ras-driven eye epithelial model. By contrast, autophagy suppresses overgrowth in the same epithelial tissue in a model with altered JNK function. Strikingly, autophagy also suppresses severe overgrowth observed in the eyes of a model involving Notch activation. Finally, we show that autophagy fails to suppress overgrowth in the eye epithelium when Hippo function is reduced, and that activation of autophagy enhances overgrowth in glia. Therefore, our results indicate a wide variety of potential influences of autophagy on cell and tissue growth, and that these may depend on both oncogenic signal and cell type.
Autophagy is a catabolic process that is activated to alleviate cell stress, and also maintains bioenergetic homeostasis under nutrient restriction. In both of these scenarios, autophagy promotes cell survival. Therefore, it is possible that the different influences of autophagy on tissue growth are related to these different survival-associated functions and the influence of either different growth or oncogenic signals on the pathways influenced by autophagy. For example, metabolism is known to be altered in many cancers, 29 and since autophagy is a catabolic process this may explain one type of cellular outcome. Alternatively, stress activates autophagy, and altered metabolism combined with a different ability to cope with stress because of altered signaling could result in a different cell and tissue outcome. Autophagy has also been implicated in cell death, and how autophagy promotes cell death also appears context dependent. 30 Therefore, many possibilities exist for how autophagy may contribute to epithelial growth.
Multiple oncogenic and growth regulatory signals have been shown to influence autophagy, and autophagy influences growth pathways. For example, mTOR directly represses autophagy by phosphorylation of Atg13, and factors upstream of mTOR, including p110, PTEN and Akt, have been shown to influence autophagy. 31 In addition, autophagy influences mTOR activity under nutrient restriction by the association of this kinase with autolysosomes that control nutrient availability and the activity of mTOR. 32, 33 In addition, both the Ras and Hippo pathways influence autophagy. 25, 34 Interestingly, activated Ras often represses autophagy, but in at least some tumor cell lines with activated Ras autophagy is activated. 35 These studies further emphasize the important relationship between nutrient sensing, growth regulatory and autophagy pathways.
The modulation of autophagy is considered to be a promising therapeutic strategy for treating cancer. Our studies highlight the importance of considering tumor genotype when autophagy is targeted for therapies. Therefore, much work is needed to better understand the potential impact of altered autophagy in different cancers. At this stage, it is unclear which tumor characteristics are best to consider when manipulating autophagy for therapeutic purposes. Our data indicating that decreased autophagy suppresses Ras-triggered overgrowth is consistent with work in mammals, but recent studies indicate that p53 status is important to consider when treating Ras-driven tumors. 6, 7 Future studies should enable us to classify tumors such that modulation of autophagy is a rational therapeutic strategy.
MATERIALS AND METHODS

Fly stocks, overexpression and clonal analysis, and quantification of overgrowth
All crosses were kept at 25°C, except where indicated. Either Canton-S or w 1118 was used as control. For induction of tissue overgrowth eyeful/Cyo (eyeless-Gal44UAS-delta, GS88A8 UAS-lola and UAS-pipsqueak), 17 eyeless-Gal4, gmr-Gal4, UAS-yorkie, 36 UAS-Ras V12 , UAS-dicer2; repo-Gal4 UAS-MCD:: GFP/TM6B, 27 yw hs-FLP; sp/Cyo; FRT82B scrib 2 /TM3, w; UAS-p35; FRT82B scrib 2 /TM6B, UAS-bsk DN ; sp/Cyo; FRT82B scrib 2 /TM6B, yw; UAS-Ras V12 FRT82B scrib 2 /TM6B, 37 w; FRT42D hippo 3D /Cyo were used. For downregulation or induction of autophagy we used lines from Vienna Drosophila RNAi Center (VDRC) and Bloomington (BL) Stock Center unless noted: Atg1 IR VDRC Transformant ID (TID) 16133, Atg6 IR TID11647, Atg12 IR BL34675, Atg5 IR BL27551, Atg4b IR TID11855, Atg4a IR TID11315, Atg8a IR TID43097, Atg8b IR TID17079, Atg3 IR TID108666, Atg9 IR TID2029, Atg7 IR TID45561, Atg18 IR TID22646, Atg1 K38Q , Atg1 6B and Atg1 GS10797 . 24, 25 To induce cell clones yw ey-FLP1; Act4y+4Gal4 UAS-GFP S65T ; FRT82B tubGal80 and yw ey-FLP; FRT42D tubulin-Gal80; tub-Gal4 UAS-CD8-GFP/T(2;3)SM5-TM6B were used. For mCherry-Atg8 analysis, we used UAS-mCherry-Atg8. 38 The UAS-Gal4 system was used to mis-express genes of interest or express RNAi against target genes. 39 MARCM (mosaic analysis with a repressible cell marker) was used to express the genes of interest or express RNAi against target genes in mutant clones. 40 For larval staging egg laying was allowed for 24 h, and larvae were aged at 25°C. Wandering 3rd instar wild-type larvae were collected and dissected on day 5. On day 12 wandering 3rd instar larvae with either UAS-Ras V12 scrib 2 or UAS-Atg1 IR UAS-Ras V12 scrib 2 MARCM clones were collected and dissected. GraphPad Prism 6 software (GraphPad Software, Inc., La Jolla, CA, USA) was used to quantify animals with overgrown eyes, secondary growths, or eye projections. Adult eye or head capsule images were taken with a Zeiss SteReo Discovery.V20 stereo microscope (Carl Zeiss AG, Jena, Germany) and processed with Zen 2012 blue edition imaging software (Carl Zeiss).
Immunostaining and microscopy
Eye-antennal or leg imaginal discs from wandering 3rd instar larvae or white prepupa were dissected and stained with the following antibodies: rabbit anti-cleaved caspase-3 (1:200, Cell Signaling Technology, Danvers, MA, USA, 9661), rabbit anti-Ref(2)P (1:2000, G Juhasz), 41 rabbit antiphospho-histone H3 (1:1000, Upstate, Billerica, MA, USA), rat anti-ELAV (1:40, Developmental Studies Hybridoma Bank, Iowa City, IA, USA, 7E8A10) and mouse anti-repo (1:20, Developmental Studies Hybridoma Bank, 8D12). FITC, Cy-3 and Cy-5 fluorescently conjugated secondary antibodies were from Jackson ImmunoResearch (West Grove, PA, USA). Vectashield mounting medium with DAPI was from Vector Laboratories (Burlingame, CA, USA). Images were obtained with a Zeiss LSM 700 confocal microscope with Zen 2012 imaging software (Carl Zeiss) and processed with Adobe Photoshop CS5.1 (San Jose, CA, USA).
Quantification and statistical analysis
Phospho-histone H3-positive cells were counted posterior to the morphogenetic furrow. Ten representative eye discs were counted for each genotype. GraphPad Prism 6 software was used to determine the average number of mitotic cells per eye disc and a P value was obtained using a two-tailed t-test. All quantitative data are shown as mean ± s.d.
